Showing 6,821 - 6,840 results of 18,392 for search 'significant ((((we decrease) OR (((nn decrease) OR (a decrease))))) OR (mean decrease))', query time: 0.82s Refine Results
  1. 6821

    Data Sheet 1_Metabolic adaptation fluctuates with different prediction equations: a secondary analysis based on a weight-loss clinical trial.docx by Molian Tang (18876955)

    Published 2025
    “…Both Katch-McArdle-determined RMR and BIA-determined RMR presented a significant decrease between baseline and the end of the intervention (week 16). …”
  2. 6822

    5.HT<sub>1A</sub> binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

    Published 2025
    “…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT<sub>1A</sub> receptor binding. …”
  3. 6823
  4. 6824

    Table 1_Age-related lung structure changes by quantitative assessment: a cross-sectional study in a Chinese male cohort.docx by Meijuan Shi (16999551)

    Published 2025
    “…LAA-950 and LAA-950% of bilateral lower lobes displayed a steeper increase began at 60 years old. We also provide a computational formula, LungAge Score, for the assessment of the structural lung aging features.…”
  5. 6825

    Discovery of Dual-Acting Biofilm Inhibitors against Pseudomonas aeruginosa by the Coupling of 3‑Hydroxypyridin-4(1<i>H</i>)‑ones with <i>N</i>‑Phenylamide QS Inhibitors by Hao-Zhong Long (19685972)

    Published 2025
    “…Mechanistic studies revealed that there was a decreased production of virulence regulated by quorum sensing system and a lack of iron acquisition under the treatment of <b>19l</b>, which led to the inhibition of biofilm. …”
  6. 6826

    Soluble average Klotho level as a prognostic marker for acute kidney injury outcomes: a 90-day follow-up study by ShaSha Li (12163175)

    Published 2025
    “…Individuals with AKI were prospectively followed up for 90 days to determine the association between their average sKlotho level and short-term AKI outcomes. Interestingly, we found that sKlotho value was significantly decreased and an alteration in the sKlotho level ran parallel to changes in kidney function in AKI patients. …”
  7. 6827
  8. 6828

    Table 1_A study of the adjunctive therapeutic effects of a 3-week bamboo forest therapy on chronic diseases in the elderly.docx by Jing He (58446)

    Published 2025
    “…Diabetic participants showed significant decreases in fasting and pre-bedtime blood glucose levels (p < 0.001), along with reduced blood glucose fluctuations post-meal. …”
  9. 6829
  10. 6830

    Table 1_Bifidobacterium compound preparations as a supplementary treatment for severe ischemic stroke: a systematic review and meta-analysis.docx by Shenghua Lu (20762612)

    Published 2025
    “…Regarding immune function, the BCP combination group significantly increased IgA (MD = 0.50, 95% CI 0.36 to 0.63, p < 0.00001) and IgG (MD = 3.00, 95% CI 2.03 to 3.97, p < 0.00001). …”
  11. 6831

    Data Sheet 1_China’s readiness for transitioning to a low-carbon economy: mitigant and catalyst factors for a geopolitical conflict.zip by Yan Chen (4308)

    Published 2025
    “…This study examines the relationship between Low-Carbon Economic Development (LCED) and Geopolitical Risk (GPR) in China by focusing on the challenges and opportunities they present. We use a qualitative analysis to identify that rising GPR, exacerbated by market instability, resource allocation conflicts, and trade disputes, significantly hinders LCED progress. …”
  12. 6832

    Profile of study locations and participants. by Hammed O. Mogaji (9421930)

    Published 2025
    “…Data analysis was conducted using R software version 4.3.2, with a 95% confidence interval.</p><p>Principal findings/conclusions</p><p>The parasitological data indicated a significant decline in the aggregated prevalence of STH across the three IUs. …”
  13. 6833

    Absolute β convergence results. by Ke Liu (121889)

    Published 2025
    “…The results revealed that from 2010 to 2020, the population agglomeration level of the Xi’an metropolitan area showed a trend of first increasing and then decreasing. …”
  14. 6834

    Conditional β convergence results. by Ke Liu (121889)

    Published 2025
    “…The results revealed that from 2010 to 2020, the population agglomeration level of the Xi’an metropolitan area showed a trend of first increasing and then decreasing. …”
  15. 6835

    Markov transition probability matrix (k = 4). by Ke Liu (121889)

    Published 2025
    “…The results revealed that from 2010 to 2020, the population agglomeration level of the Xi’an metropolitan area showed a trend of first increasing and then decreasing. …”
  16. 6836

    Markov transition probability matrix (k = 4). by Ke Liu (121889)

    Published 2025
    “…The results revealed that from 2010 to 2020, the population agglomeration level of the Xi’an metropolitan area showed a trend of first increasing and then decreasing. …”
  17. 6837

    Regression results. by Ke Liu (121889)

    Published 2025
    “…The results revealed that from 2010 to 2020, the population agglomeration level of the Xi’an metropolitan area showed a trend of first increasing and then decreasing. …”
  18. 6838

    Identification of narciclasine as a novel NRF2 inhibitor by Hoang Hai Ngo (20564072)

    Published 2025
    “…Finally, we observed that administration of narciclasine significantly decreased the growth of A549 xenografts. …”
  19. 6839

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  20. 6840

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”